agilon health appoints Jeff Schwaneke as CFO, replacing retiring Tim Bensley effective July 1, 2024

agilon health, inc.

Jeff Schwaneke, former Centene CFO (2016-2021) and EVP Health Care Enterprises, named CFO and EVP effective July 1, 2024.
Schwaneke steps down from agilon board; compensation includes $625K base salary, 75% target bonus, $2.5M RSUs, $1M PSUs with 100% share price hurdle, plus $300K cash sign-on.
Timothy Bensley announced earlier retirement in early 2024 and will remain through a transition period.
Schwaneke brings 27+ years finance experience, including 15 in managed care; Centene revenues grew from $20B to $125B during his CFO tenure.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Jeff Schwaneke

Director

AGL · agilon health, inc.

Effective: 2024-07-01
Filed: June 5, 2024, 7:59 PM ET

In connection with his appointment, Mr. Schwaneke will resign from the agilon health, inc. Board of Directors.

Appointed

Jeff Schwaneke

Chief Financial Officer and Executive Vice President

AGL · agilon health, inc.

Effective: 2024-07-01
Filed: June 5, 2024, 7:59 PM ET

On June 4, 2024, agilon health, inc. (the “Company”) appointed Jeff Schwaneke to serve as the Company’s Chief Financial Officer and Executive Vice President effective July 1, 2024 (the “Effective Date”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.9

Jeff Schwaneke resigned as Director at agilon health, inc..

Action: resigned
Role: Director

Exact text from the filing

In connection with his appointment, Mr. Schwaneke will resign from the agilon health, inc. Board of Directors.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Jeff Schwaneke was appointed as Chief Financial Officer and Executive Vice President at agilon health, inc..

Action: appointed
Role: Chief Financial Officer and Executive Vice President

Exact text from the filing

On June 4, 2024, agilon health, inc. (the “Company”) appointed Jeff Schwaneke to serve as the Company’s Chief Financial Officer and Executive Vice President effective July 1, 2024 (the “Effective Date”).

View on SEC.gov

agilon health, inc. filing history →

Source: SEC EDGAR

accession 0001628280-24-026758

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.